Michael Sarcone
Stock Analyst at Jefferies
(0.36)
# 4,475
Out of 4,479 analysts
4
Total ratings
50%
Success rate
-25.47%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $118.98 | +5.06% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $8.58 | +16.55% | 1 | Mar 21, 2023 | |
| AXGN AxoGen | Assumes: Buy | $15 | $7.52 | +99.47% | 1 | Nov 11, 2022 | |
| EDAP EDAP TMS | Initiates: Buy | $11 | $5.30 | +107.55% | 1 | Nov 1, 2022 |
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $118.98
Upside: +5.06%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $8.58
Upside: +16.55%
AxoGen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $7.52
Upside: +99.47%
EDAP TMS
Nov 1, 2022
Initiates: Buy
Price Target: $11
Current: $5.30
Upside: +107.55%